Navigation Links
ICON®microALB

ProductsICON®microALB
Company Beckman Coulter, Inc.
Item ICON®microALB
Features 
  • CLIA Waived
  • 18 mg/L sensitivity, 95% specificity
  • Albumin specific
  • Results in 3 minutes, readable up to 8 hours
  • Room temperature storage
  • Description ICON®microALB is a qualitative immunoassay for urinary albumin that allows for early detection of kidney disease. This albumin specific, CLIA Waived test has a sensitivity of 18 mg/L and specificity of 95%, and gives accurate results in only 3 minutes with stable viewing results up to 8 hours. Since early detection is one key to preventing kidney disease, the ICON®microALB allows the clinician to easily meet the National Kidney Foundation and American Diabetes Association guidelines for annual screening and has a unique design that allows for easy handling, superior readability and patient labeling right on the device. The ICON®microALB can be stored at room temperature and each dipstick is individually wrapped. Add this annual screening test to your Point-of-Care arsenal.
    Info Beckman Coulter, Inc.
    Customer Service: (800) 742-2345
    Web site: http://www.beckmancoulter.com

    Related medicine products :

    1. Donna® Saliva Ovulation Tester
    2. QED A350 Saliva Alcohol Test
    3. QED® A150 Saliva Alcohol Test
    4. Cortisol (Saliva)
    5. Cortisol, Saliva
    6. IgA, Saliva
    7. Immunoglobulin A, Saliva
    8. Alcoholic Giemsa Stain
    9. Ammonia/Alcohol Control
    10. Isopropyl Alcohol Liquid Pouch
    11. Acetone Alcohol Saturated Swabsticks
    ... Stryker Universal ACL Instrumentation System has ... a variety of anterior cruciate ligament ... Universal ACL Instrumentation system and endoscopic ... obtain more reproducible anatomical graft placement ...
    This optimal design addresses low-cost, simple, non-invasive ankle distraction....
    A straightforward, versatile approach to arthroscopically assisted pin placement in either the ankle or wrist....
    ... The BTA stat Test is ... the qualitative detection of bladder ... diagnosed with bladder cancer. This ... an aid in the management of ...
    Medicine Products:
    (Date:12/7/2016)... ... December 07, 2016 , ... ... medicine device WellnessPro Plus for consumers and healthcare professionals to manage chronic ... by expanding the treatment modalities available in a single device. The announcement ...
    (Date:12/7/2016)... ... ... “Tomorrow Trump Goes To Washington”: a brief but engaging illustration depicting ... America. “Tomorrow Trump Goes To Washington” is the creation of published author, Nancy Engestrom, ... , Nancy attributes her patriotic nature to her WWII veteran father. She says, ...
    (Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... Angioma Alliance ( http://www.angioma.org ... angiomas, was awarded a grant from the Julian Grace Foundation to increase its ... more people with cavernous angioma than anywhere in the world. Most share a ...
    (Date:12/7/2016)... Mateo, CA (PRWEB) , ... December 07, 2016 , ... ... San Francisco Peninsula region, is proud to announce new city-specific pages as part of ... services for the elderly, they often look, first, for local agencies serving their city. ...
    (Date:12/6/2016)... ... December 06, 2016 , ... ... collaborate in developing a vaccine against the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). ... available in South Korea for emergency deployment in the event of a future ...
    Breaking Medicine News(10 mins):
    (Date:12/7/2016)... Dec. 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ... present a company overview at the BMO Capital Markets Prescriptions for ... York, NY . A live webcast of the ... the Ionis website.  The replay will be available within 48 hours ... ...
    (Date:12/7/2016)... 7, 2016  Lannett Company, Inc. (NYSE: LCI ) ... Markets 2016 Prescription for Success Healthcare Conference on December 14, 2016 ... New York City . In addition, the ... Guggenheim Securities 4 th Annual Boston Healthcare Conference taking place ... ...
    (Date:12/6/2016)...  Alopexx Oncology, LLC announced data from a Phase ... (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal antibody. ... cells as Rituxan and maintains the activities of both ... in tumor targeting, engagement of the immune system, and ... the study (abstract #95954) were presented at the 58 ...
    Breaking Medicine Technology: